Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Dana-Farber Cancer Institute, Inc. v. Ono Pharmaceutical Co., Ltd. et al
Case Number:
1:15-cv-13443
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
May 17, 2019
American Researchers To Be Added To Nobel-Related Patents
Two American scientists will be added to patents involved in Nobel Prize-winning cancer research, a Boston federal judge ruled Friday, handing a victory to the Dana-Farber Cancer Institute and Foley Hoag LLP.
-
February 22, 2019
US Scientists Belong On Cancer Patents, Judge Hears
The success of a lawsuit to add two American scientists to patents for Nobel Prize-winning cancer research will hinge on establishing that the pair's research was significant to the ultimate invention, the Boston federal judge overseeing the case indicated Friday at closing arguments in an eight-day bench trial.
-
February 04, 2019
11th-Hour Deal Lets Pfizer Exit As Cancer Patent Trial Begins
Pfizer Inc. and Bristol-Myers Squibb Co. reached a settlement on the eve of a trial in Boston on Monday in which Dana-Farber Cancer Institute is seeking to add two American researchers to patents for Nobel Prize-winning cancer research, a development that surprised the judge but still left key elements of the dispute unresolved.
-
December 01, 2017
Pfizer, Dana-Farber Win Bid For Bristol-Myers Docs In IP Suit
Pfizer Inc. and the Dana-Farber Cancer Institute were allowed access on Friday to what a Boston federal judge described as critical information guarded by Bristol-Myers Squibb Co. and development partner Ono Pharmaceutical Co. Ltd. in a claim seeking to add two American researchers to six cancer immunotherapy patents.